I-VAC
Toolkit

Last Updated April 21, 2022

COVID-19 VACCINE ADMINISTRATION
SELF-GUIDED EDUCATION MODULES

This COVID-19 Vaccination Administration Toolkit has been developed as part of the I-VAC program administered by The Illinois Chapter, American Academy of Pediatrics (ICAAP) in partnership with the Extension for Community Health Outcomes (ECHO)-Chicago at the University of Chicago and the Illinois Academy of Family Physicians (IAFP).

This toolkit is specifically designed to aide providers and provider organizations in developing effective tactics for the incorporation of COVID-19 vaccination into their regular patient workflows. This toolkit is not meant to replace required trainings for healthcare providers and organizations, but to act as supplemental information to help drive more efficient vaccine implementation throughout Illinois.

The information provided within these toolkits and on this landing page was last updated on April 21, 2022.

This Toolkit Includes Information and Resources On:

  • COVID-19 vaccine administration and distribution (I-CARE, working with local health departments, etc.)
  • Operational issues
  • Handling and preparation of COVID-19 vaccines
  • Post-vaccine process
  • Implementing COVID-19 vaccine mandates in your workplace
  • Strategies for overcoming vaccine hesitancy through culturally and linguistically appropriate methods
  • How to use data to support vaccine uptake

HOW TO USE THIS TOOLKIT

Providers and provider organizations may either download the complete toolkit or individual sections based on their needs. Each toolkit section includes an interactive PDF with live links to key resources and source material.

All resources and source material links for each toolkit section can be found under the “Resources” portion of this page, organized by section and page number.

Woman Being Vaccinated

Download Toolkit

Last Updated April 21, 2022

Download
Purpose of This Toolkit
Download
About
Download
Becoming a Vaccinator
Download
Vaccine Ordering, Storage, and Handling
Download
Vaccine Administration
Download
Clinical Considerations
Download
Download
Additional Considerations
Download

RESOURCE LINKS

If you are using the printed version of the self-guided COVID-19 vaccination toolkit, please use the resource guide below to view all corresponding resources and source material by section. Here you will find all the links to each resource referenced within the toolkit.

5-5

Appendix C

Considerations for Janssen COVID-19 Vaccine

5-6

Appendix C

Considerations for mRNA COVID-19 vaccines: Pfizer-BioNTech and Moderna

Considerations for Janssen COVID-19 Vaccine

5-7

Appendix C

Clinical Immunization Safety Assessment COVIDvax

Appendix C

Appendix D

Managing Anaphylaxis

5-8

Clinical Immunization Safety Assessment COVIDvax

CDC: Use of COVID-19 Vaccines in the United States

CDC: Contraindications and Precautions

Illinois.gov: Vaccination Eligibility

5-9

CDC’s latest recommendations

5-10

CDC’s Guidance

5-12

CDC’s Guidance

5-13

CDC: Use of COVID-19 Vaccines in the United States

CDC: Use of COVID-19 Vaccines in the United States

CDC: COVID-19 Vaccine Boosters

CDC: Updates to the Evidence to Recommendation Framework: Pfizer-BioNTech and Moderna COVID-19 vaccine booster doses

5-14

COVID-19 Vaccine: Vaccine Administration Competencies Assessment Form-February 28, 2021

5-15

For supplementary material on Intramuscular Injection Children 7 through 18 years of age please follow this PDF.

CDC: Vaccine Administration: Needle Gauge and Length

5-16

CDC: Use of COVID-19 Vaccines in the United States

5-17

Encourage patients to enroll in V-SAFE

CDC: How to Increase COVID-19 Vaccination upon Discharge from Hospitals, Emergency Departments & Urgent Care Facilities

5-18

From the CDC: There is no VIS for COVID-19 vaccines authorized under an EUA. Instead, the FDA-issued EUA Fact Sheet for Recipients and Caregivers for each COVID-19 vaccine must be used.

CDC: Healthcare Providers/ Professionals

5-19

CDC: Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination

5-21

Here: IDPH Account Portal

IDPH: Vax Verify

5-23

CDC: v-safe After Vaccination Health Checker

5-26

To sign up for this program, patients can use this link and fill out the form.

5-27

Far South Region – Protect Chicago at Home Program

Near South Region – Protect Chicago at Home Program

North/Central Region – Protect Chicago at Home Program

Northwest Region – Protect Chicago at Home Program

Southwest Region – Protect Chicago at Home Program

West Region – Protect Chicago at Home Program

5-28

DuPage County COVID-19 Vaccine Registration

5-29

Will County In-Home COVID-19 Vaccination Contact Form

5-31

U.S. COVID-19 Vaccine Product Information

Moderna COVID-19 Vaccine: Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older

Pfizer-BioNTech COVID-19 Vaccine: 5 Through 11 Years of Age • Standing Orders for Administering Vaccine

12 Years of Age and Older (Gray Cap) Pfizer-BioNTech COVID-19 Vaccine Standing Orders for Administering Vaccine

Janssen COVID-19 Vaccine (Johnson & Johnson) Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older

6-3

Pfizer Local & Systematic Reactions

Moderna Local & Systematic Reactions

J&J Local & Systematic Reactions

6-6

CDC: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination

6-7

CDC Center for Preparedness and Response

CDC: Pfizer/BioNTech BNT162b2 (COVID-19 Vaccine, mRNA) Vaccine –in Individuals 5 to <12 Years of Age

6-8

VAERS: Writable PDF Form

VAERS: Upload Completed Writable PDF Form

CDC: Reporting Adverse Events Following Vaccination

6-12

CDC: COVID-19 Vaccine Administration Errors and Deviations

6-13

CDC: Science Brief

CDC: Morbidity and Mortality Weekly Report, January 14, 2022

6-14

COVID-19 Vaccines for Moderately or Severely Immunocompromised People

6-15

CDC’s Guidance on Vaccinations Given Outside of the US

Chart Source

Moderately or Severely Immunocompromised

6-16

Moderately or Severely Immunocompromised

EUI (Chart Footnotes)

Emergency Use by WHO (Chart Footnotes)

Chart Source

6-17

Moderately or Severely Immunocompromised

Special Situations Guidance

EUI (Chart Footnotes)

Emergency Use by WHO (Chart Footnotes)

Chart Source

COVID-19 Vaccines Listed for Emergency Use by WHO

6-18

WHO-EUL COVID-19 Vaccines

CDC: Emergency Use Instructions (EUI) Fact Sheet for Recipients and Caregivers: Pfizer-BioNTech COVID-19 Vaccine for Primary, Additional, and/or Booster Doses

6-19

Stillbirths

CDC: COVID-19 Vaccines While Pregnant or Breastfeeding

6-21

January 2022 Study

2022 MMWR Study

2021 MMWR Study

CDC: COVID-19 Vaccines While Pregnant or Breastfeeding

ACOG Guidelines

6-22

Illinois.gov Guidance Affirming Non-Discrimination in Medical Treatment

CDC: People with Disabilities

CDC’s Website